loader
Please Wait
Applying Filters...

Polpharma European CDMO Partner & API Manufacturer since 1951 Polpharma European CDMO Partner & API Manufacturer since 1951

X

Technical details about Elamipretide, learn more about the structure, uses, toxicity, action, side effects and more

Client Email Product
Menu
2D Structure
1. Also known as: 736992-21-5, Bendavia, Mtp-131, Ocuvia, Mtp 131, Rx 31
Molecular Formula
C32H49N9O5
Molecular Weight
639.8  g/mol
InChI Key
SFVLTCAESLKEHH-WKAQUBQDSA-N
FDA UNII
87GWG91S09

Elamipretide has been used in trials studying the treatment of Leber's Hereditary Optic Neuropathy.
1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(2S)-6-amino-2-[[(2S)-2-[[(2R)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl]amino]-N-[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]hexanamide
2.1.2 InChI
InChI=1S/C32H49N9O5/c1-19-15-22(42)16-20(2)23(19)18-27(41-29(44)24(34)11-8-14-38-32(36)37)31(46)39-25(12-6-7-13-33)30(45)40-26(28(35)43)17-21-9-4-3-5-10-21/h3-5,9-10,15-16,24-27,42H,6-8,11-14,17-18,33-34H2,1-2H3,(H2,35,43)(H,39,46)(H,40,45)(H,41,44)(H4,36,37,38)/t24-,25+,26+,27+/m1/s1
2.1.3 InChI Key
SFVLTCAESLKEHH-WKAQUBQDSA-N
2.1.4 Canonical SMILES
CC1=CC(=CC(=C1CC(C(=O)NC(CCCCN)C(=O)NC(CC2=CC=CC=C2)C(=O)N)NC(=O)C(CCCN=C(N)N)N)C)O
2.1.5 Isomeric SMILES
CC1=CC(=CC(=C1C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N)NC(=O)[C@@H](CCCN=C(N)N)N)C)O
2.2 Other Identifiers
2.2.1 UNII
87GWG91S09
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Arg-dmt-lys-phe-nh2

2. Arginyl-2,'6'-dimethyltyrosyl-lysyl-phenylalaninamide

3. Bendavia

4. D-arg-dmt-lys-phe-nh2

5. Mtp-131

6. Ss-31 Peptide

7. Ss31 Peptide

2.3.2 Depositor-Supplied Synonyms

1. 736992-21-5

2. Bendavia

3. Mtp-131

4. Ocuvia

5. Mtp 131

6. Rx 31

7. Ss 31

8. L-phenylalaninamide, D-arginyl-2,6-dimethyl-l-tyrosyl-l-lysyl-

9. Unii-87gwg91s09

10. Szeto-schiller Peptide

11. Rx-31

12. Ss-31

13. Nh2-d-arg-dmt-lys-phe-nh2

14. 87gwg91s09

15. D-arginyl-2,6-dimethyl-l-tyrosyl-l-lysyl-l-phenylalaninamide

16. (2s)-6-amino-2-[[(2s)-2-[[(2r)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl]amino]-n-[(2s)-1-amino-1-oxo-3-phenylpropan-2-yl]hexanamide

17. (s)-6-amino-n-((s)-1-amino-1-oxo-3-phenylpropan-2-yl)-2-((s)-2-((r)-2-amino-5-guanidinopentanamido)-3-(4-hydroxy-2,6-dimethylphenyl)propanamido)hexanamide

18. Ss-31 Peptide

19. Arg-dmt-lys-phe-nh2

20. D-arg-dmt-lys-phe-nh2

21. Ss31 Peptide

22. Elamipretide [inn]

23. Elamipretide [usan:inn]

24. Elamipretide (usan/inn)

25. Elamipretide [usan]

26. Elamipretide (mtp-131)

27. Elamipretide [who-dd]

28. Arginyl-2,'6'-dimethyltyrosyl-lysyl-phenylalaninamide

29. Chembl3833370

30. Schembl15028020

31. Dtxsid50471988

32. Ss-31mtp-131

33. Hy-p0125

34. S9803

35. Zinc43130902

36. Cs-5846

37. Db11981

38. D10925

39. D78262

40. A901134

41. Q27269822

2.4 Create Date
2006-10-26
3 Chemical and Physical Properties
Molecular Weight 639.8 g/mol
Molecular Formula C32H49N9O5
XLogP30
Hydrogen Bond Donor Count9
Hydrogen Bond Acceptor Count8
Rotatable Bond Count19
Exact Mass639.38566570 g/mol
Monoisotopic Mass639.38566570 g/mol
Topological Polar Surface Area267 Ų
Heavy Atom Count46
Formal Charge0
Complexity991
Isotope Atom Count0
Defined Atom Stereocenter Count4
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Post Enquiry
POST ENQUIRY